Deoxyuridine

Deoxyuridine

SCHEMBL28844

O=c1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DUT P33316 3/20 0.64
TK1 P04183 3/20 0.62
LMNA P02545 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
SLC28A1 O00337 1/20 0.60
SLC28A2 O43868 1/20 0.60
SLC29A1 Q99808 1/20 0.60
SLC28A3 Q9HAS3 1/20 0.60
ALOX12 P18054 1/20 0.58
ADRA1A P35348 1/20 0.58
TK2 O00142 1/20 0.57
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
TSHR P16473 1/20 0.56
BLM P54132 1/20 0.56
PMP22 Q01453 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Deoxyuridine SCHEMBL9219261 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL2641582 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL889540 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL114598 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL19841232 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL9708874 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL24512520 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL4847464 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL391224 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1
Deoxyuridine SCHEMBL9219265 1.00 DUT (0.64) DUTTK1LMNASMN1; SMN2SLC28A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 23380 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260146270-A1 NOVEL ENZYMATIC METHODS TO GENERATE HIGH YIELDS OF SEQUENCE SPECIFIC RNAS WITH EXTREME PRECISION THE UNIVERSITY OF MASSACHUSETTS (US) 2026-05-28 US claimed
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 EP claimed
CN-122081492-A Intracellular imaging system for simultaneously detecting UDG and miR-375 expression levels and application thereof 2026-05-26 CN claimed
CN-122071741-A Probe for noninvasive risk classification of neuroblastoma, marker combination and prediction method of probe 河南省儿童医院郑州儿童医院 2026-05-22 CN claimed
US-12630851-B2 Polynucleotide modification methods OXFORD NANOPORE TECHNOLOGIES PLC (GB) 2026-05-19 US claimed
CN-121428075-B High-flux ubiquitin sample protein interaction screening method 良渚实验室 2026-05-15 CN claimed
EP-4739343-A2 CIRCULAR RNA VACCINES FOR SEASONAL FLU AND METHODS OF USES Shanghai Circode Biomed Co., Ltd (CN) 2026-05-13 EP claimed
WO-2026090322-A1 COMPOSITIONS AND METHODS FOR PERFORMING SPATIALLY RESOLVED TRANSCRIPTOMICS NEW YORK GENOME CENTER, INC. (US) 2026-04-30 WO claimed
US-20260109728-A1 IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE TALLAC THERAPEUTICS INC (US) 2026-04-23 US claimed
US-20260109989-A1 COMPOSITIONS AND METHODS FOR THE SYNTHESIS AND IDENTIFICATION OF COVALENT APTAMERS UNIV HAWAII (US) 2026-04-23 US claimed
EP-0149775-A1 Compositions of nucleic acid components OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1985-07-31 EP claimed
WO-1985001871-A1 METHOD AND MATERIALS FOR SENSITIZING NEOPLASTIC TISSUE TO RADIATION GREER SHELDON B 1985-05-09 WO claimed
US-4472572-A Adenosine pyrophosphate polynucleotide compound INNOVAX LABORATORIES, LTD. (US) 1984-09-18 US claimed
EP-0099922-A1 COMPOSITION AND METHOD FOR FORMING A5'p5'pN3'p(AppNp) INNOVAX LABORATORIES, LTD (US) 1984-02-08 EP claimed
EP-0097039-A1 5-(E-2-halovinyl)-2'-deoxyuridine derivatives, processes for their preparation, pharmaceutical compositions containing them, and their use in treating viral infections BEECHAM GROUP PLC (GB) 1983-12-28 EP claimed
US-4418059-A HALO-DEOXYURIDINE-BILE ACID ESTERS, ANTITUMOR AGENTS MONTEFIORE MEDICAL CENTER (US) 1983-11-29 US claimed
EP-0090837-A1 METHOD AND COMPOSITION FOR TREATING A PATIENT SUFFERING FROM INTERFERONSUSCEPTIBLE DISORDER BERG, Kurt Frimann (DK) 1983-10-12 EP claimed
WO-1983002616-A1 COMPOSITION AND METHOD FOR FORMING A5'p5'pn3'p (AppNp) INNOVAX LAB LTD (US) 1983-08-04 WO claimed
WO-1983001198-A1 METHOD AND COMPOSITION FOR TREATING A PATIENT SUFFERING FROM INTERFERON-SUSCEPTIBLE DISORDER BERG, KURT, FRIMANN 1983-04-14 WO claimed
US-4302437-A Mitogen stimulated lymphocyte transformation HERBERT VICTOR 1981-11-24 US claimed